Literature DB >> 761338

Propranolol in the treatment of angina pectoris. Comparison of duration of action in acute and sustained oral therapy.

U Thadani, J O Parker.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 761338     DOI: 10.1161/01.cir.59.3.571

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  7 in total

1.  Dissociation between duration of plasma catecholamine and blood pressure responses to beta-adrenergic blockade in normotensive subjects during physical exercise.

Authors:  G Planz; R Planz
Journal:  Eur J Clin Pharmacol       Date:  1981-01       Impact factor: 2.953

Review 2.  Postinfarction use of beta-blockers in elderly patients.

Authors:  W S Aronow
Journal:  Drugs Aging       Date:  1997-12       Impact factor: 3.923

3.  Erythrocytes as barriers for drug elimination in the isolated rat liver. II. Propranolol.

Authors:  H J Lee; W L Chiou
Journal:  Pharm Res       Date:  1989-10       Impact factor: 4.200

4.  Abrupt withdrawal of atenolol in patients with severe angina. Comparison with the effects of treatment.

Authors:  P R Walker; A J Marshall; S Farr; B Bauminger; G Walters; D W Barritt
Journal:  Br Heart J       Date:  1985-03

5.  Trimetazidine: a new concept in the treatment of angina. Comparison with propranolol in patients with stable angina. Trimetazidine European Multicenter Study Group.

Authors:  J M Detry; P Sellier; S Pennaforte; D Cokkinos; H Dargie; P Mathes
Journal:  Br J Clin Pharmacol       Date:  1994-03       Impact factor: 4.335

6.  Concentration-effect and time-effect relationships of carteolol.

Authors:  T Ishizaki; A Ohnishi; T Sasaki; K Chiba; T Suganuma; K Kushida
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

Review 7.  The pharmacokinetics of lignocaine and beta-adrenoceptor antagonists in patients with acute myocardial infarction.

Authors:  S Nattel; G Gagne; M Pineau
Journal:  Clin Pharmacokinet       Date:  1987-11       Impact factor: 6.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.